313 Frequency and acceptance of CDSS-generated STOPP/START signals - SI Table SI1.1. Continued. STOPP criteria (n=79) All countries Belgium (BE) Switzerland (CH) Ireland (IE) The Netherlands (NL) Frequency (N) Acceptance (%) Frequency (N) Acceptance (%) Frequency (N) Acceptance (%) Frequency (N) Acceptance (%) Frequency (N) Acceptance (%) J 2. Thiazolidenediones (e.g. rosiglitazone, pioglitazone) in patients with heart failure 0 N/A 0 N/A 0 N/A 0 N/A 0 N/A J 4. Oestrogens with a history of breast cancer or venous thromboembolism 0 N/A 0 N/A 0 N/A 0 N/A 0 N/A M 1. Concomitant use of two or more drugs with antimuscarinic/anticholinergic properties (e.g. bladder antispasmodics, intestinal antispasmodics, tricyclic antidepressants, first generation antihistamines) 0 N/A 0 N/A 0 N/A 0 N/A 0 N/A 4
RkJQdWJsaXNoZXIy MTk4NDMw